CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash and cash equivalents	$ 96,686	$ 148,029
Patient accounts receivable, net	99,740	76,078
Prepaid expenses and other current assets	47,860	42,413
Total current assets	244,286	266,520
NONCURRENT ASSETS
Property and equipment, net	190,694	152,242
Intangible assets, net	282,088	300,355
Goodwill	1,243,721	1,204,544
Other noncurrent assets	7,888	3,448
Total noncurrent assets	1,724,391	1,660,589
Total assets	1,968,677	1,927,109
CURRENT LIABILITIES
Accounts payable	12,941	14,152
Accrued payroll expenses	61,215	60,002
Other accrued expenses	26,209	26,510
Current portion of contingent consideration	8,984	14,123
Other current liabilities	2,191	1,965
Total current liabilities	111,540	116,752
NONCURRENT LIABILITIES
Long-term debt, net	203,364	157,416
Other noncurrent liabilities	64,538	50,325
Contingent consideration, net of current portion	3,653	3,307
Deferred tax liability, net	54,281	54,281
Total noncurrent liabilities	325,836	265,329
Total liabilities	437,376	382,081
COMMITMENT AND CONTINGENCIES (see Note 14)
STOCKHOLDERS' EQUITY
Preferred stock - par value $0.01 per share; 25,000 shares authorized as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021	0	0
Common stock - par value $0.01 per share; 800,000 shares authorized as of June 30, 2022 and December 31, 2021; 376,181 and 374,255 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	3,763	3,743
Additional paid-in capital	2,015,665	1,898,357
Accumulated deficit	(488,127)	(357,072)
Total stockholders' equity	1,531,301	1,545,028
Total liabilities and stockholders' equity	$ 1,968,677	$ 1,927,109